ReviewVeterinary research communications2026
Green-synthesized gold nanoparticles: as emerging tools to combat antimicrobial resistance and therapeutic applications in poultry.
Review in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) nowadays has become a serious concern for poultry industry due to rapidly growing microbes. The frequent and overuse of antimicrobial drugs in the past few decades has raised serious queries in terms of AMR. To overcome AMR, various natural products, including probiotics, phytochemicals, and nanoparticles, have emerged as promising therapeutic alternatives. Among all, green-synthesized nanoparticles are increasingly being adopted to restore gut health and disease resilience. Green synthesis of gold nanoparticles (AuNPs) is a revolutionary technique in veterinary medicine. Their synthesis involves natural biomolecules, microorganisms, and plant extracts, rather than traditional chemicals. They can improve the therapeutic potential by causing damage to lethal pathogens of poultry, including bacteria, viruses, and protozoans. These nanoparticles rupture the bacterial cell wall and cell membrane, causing inhibition of biofilm formation, producing reactive oxygen species (ROS), causing oxidative stress. They also cause hindrance to the electron transport chain (ETC) and ultimately lead to leakage of cytoplasmic contents. They can also be used as additives along with antibiotics to demonstrate synergistic effects, providing a broad attacking strategy. However, AuNPs have several limitations, including resistance against pathogenic microbes, but the main focus of the study is to develop multifunctional NPs that have multiple functions in a single structure, like integrating antimicrobials, gene therapy, imaging, target drug delivery, real-time monitoring of infection, gene suppression resistance, diagnostic, and theranostics agents. This review discusses the green synthesis of AuNPs, their antimicrobial potential, applications, and how they combat disease-causing AMR pathogens, as well as their limitations and future perspectives, along with their physicochemical characteristics.
Indexed as
Identifiers
41870753What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.